AbbVie Inc.

ABBV
HealthcareDividend King
$286.20
2.42%Overvalued

AbbVie Inc. (ABBV) is a Healthcare company that currently yields 2.42% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $148.57 and the overvaluation threshold at $233.63. AbbVie Inc. holds a quality score of 45/100 (Average), reflecting 54 consecutive years of dividend growth with a 117% payout ratio. The 5-year dividend CAGR stands at 6.8%.

ABBV Dividend Yield History — Weiss Valuation

Underval. $148.57Overval. $233.63

Distance to undervalued

Entry price is stretched

Needs 48.1% downside to reach the Weiss buy zone

Undervaluation starts near $148.57, where the annual dividend would imply roughly 4.66% yield. That is 2.24% above today's yield.

Buy-zone price

$148.57

Target yield

4.66%

Research checklist

What to clear before buying the yield

Updated Nov 21, 2026

Dividend durability

54Y

Long dividend history supports a deeper look.

Earnings payout

117%

Coverage deserves a closer look in filings.

Cash payout

69%

Free cash flow coverage supports the payment.

Dividend growth

6.8%

Recent growth adds income compounding potential.

What changed

What changed since the last update

2026-11-20 → 2026-11-21

No major change in signal, yield, price, quality, or payout since the last update.

Why Now?

AbbVie Inc. is trading near its historical overvaluation band.

Current yield 2.4% vs historical max 6.6% (37% of maximum).

12 consecutive years without a dividend cut.

Elevated payout ratio of 117%.

What matters now

Read the signal before the headline yield

Valuation is the brake here: the yield is compressed versus its own history.

The 45/100 quality score says the headline yield needs extra skepticism.

The earnings payout ratio is above 100%, so coverage is the first risk to unpack.

ABBV Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$258

Year 10 Income

$631

Yield on Cost

6.61%

Total Income

$4,150

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Track actual vs. projected

See what ABBV dividends you actually received with Sharesight

Dividend income log · Yield on cost · DRIP cost basis · Tax reports

→

More research

Full price history & technical analysis

TradingView ↗

Fundamentals, valuation & analyst ratings

FinViz ↗

Moat rating & analyst fair value

Morningstar ↗

Track dividends received & tax reports

Sharesight ↗

ABBV Dividend Quality Score

Quality Score

45/ 100

Average

Payout Ratio0/25
Dividend Streak20/25
Growth (CAGR 5Y)15/20
Yield vs History0/15
FCF Coverage10/15

Key Metrics

Current Price$286.20
Annual Dividend$6.92
Current Yield2.42%
Yield — Max (10Y)6.55%
Yield — Min (10Y)3.25%
Undervalued Below$148.57
Overvalued Above$233.63
Payout Ratio117.35%
CAGR Dividend 5Y6.8%
CAGR Dividend 10Y12.5%
Years No Cut12y

Invest in ABBV

Check AbbVie Inc. availability and current costs on eToro

Check eToro terms and availability →
Fractional sharesFees vary by countryCapital at risk

DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.

54
consecutive years of dividend growth